首页 > 分享 > Probiotics for treatment of bacterial diarrhea in pet animals

Probiotics for treatment of bacterial diarrhea in pet animals

萌宠菠菠乐园
2024-08-19 02:24

[1] 王海棚, 刘燕, 朱金凤. 宠物行业现状及发展趋势. 河南农业, 2019(2): 50-51. [2] Hubbard K, Skelly BJ, McKelvie J, Wood JLN. Risk of vomiting and diarrhoea in dogs. Veterinary Record, 2007, 161(22): 755-757. DOI:10.1136/vr.161.22.755 [3] Singleton DA, Arsevska E, Smyth S, Barker EN, Jewell C, Brant B, Sánchez-Vizcaíno F, Dawson S, Pinchbeck GL, Noble PJM, Jones PH, Radford AD. Small animal disease surveillance:gastrointestinal disease, antibacterial prescription and Tritrichomonas foetus. Veterinary Record, 2019, 184(7): 211-216. DOI:10.1136/vr.l722 [4] Jones PH, Dawson S, Gaskell RM, Coyne KP, Tierney Á, Setzkorn C, Radford AD, Noble PJM. Surveillance of diarrhoea in small animal practice through the small animal veterinary surveillance network (SAVSNET). The Veterinary Journal, 2014, 201(3): 412-418. DOI:10.1016/j.tvjl.2014.05.044 [5] Viswanathan VK, Hodges K, Hecht G. Enteric infection meets intestinal function:How bacterial pathogens cause diarrhoea. Nature Reviews Microbiology, 2009, 7(2): 110-119. DOI:10.1038/nrmicro2053 [6] Marks SL, Kather EJ. Bacterial-associated diarrhea in the dog:a critical appraisal. The Veterinary Clinics of North America:Small Animal Practice, 2003, 33(5): 1029-1060. DOI:10.1016/S0195-5616(03)00091-3 [7] Sokolow SH, Rand C, Marks SL, Drazenovich NL, Kather EJ, Foley JE. Epidemiologic evaluation of diarrhea in dogs in an animal shelter. American Journal of Veterinary Research, 2005, 66(6): 1018-1024. DOI:10.2460/ajvr.2005.66.1018 [8] Puñ o-Sarmiento J, Medeiros L, Chiconi C, Martins F, Pelayo J, Rocha S, Blanco J, Blanco M, Zanutto M, Kobayashi R, Nakazato G. Detection of diarrheagenic Escherichia coli strains isolated from dogs and cats in Brazil. Veterinary Microbiology, 2013, 166(3/4): 676-680. [9] Reimschuessel R, Grabenstein M, Guag J, Nemser SM, Song K, Qiu JS, Clothier KA, Byrne BA, Marks SL, Cadmus K, Pabilonia K, Sanchez S, Rajeev S, Ensley S, Frana TS, Jergens AE, Chappell KH, Thakur S, Byrum B, Cui J, Zhang Y, Erdman MM, Rankin SC, Daly R, Das S, Ruesch L, Lawhon SD, Zhang SP, Baszler T, Diaz-Campos D, Hartmann F, Okwumabua O. Multilaboratory survey to evaluate Salmonella prevalence in diarrheic and nondiarrheic dogs and cats in the United States between 2012 and 2014. Journal of Clinical Microbiology, 2017, 55(5): 1350-1368. DOI:10.1128/JCM.02137-16 [10] Weese JS, Staempfli HR, Prescott JF, Kruth SA, Greenwood SJ, Weese HE. The roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in diarrhea in dogs. Journal of Veterinary Internal Medicine, 2001, 15(4): 374-378. [11] Adams RJ, Kim SS, Mollenkopf DF, Mathys DA, Schuenemann GM, Daniels JB, Wittum TE. Antimicrobial-resistant Enterobacteriaceae recovered from companion animal and livestock environments. Zoonoses and Public Health, 2018, 65(5): 519-527. DOI:10.1111/zph.12462 [12] Bacci C, Vismarra A, Dander S, Barilli E, Superchi P. Occurrence and antimicrobial profile of bacterial pathogens in former foodstuff meat products used for pet diets. Journal of Food Protection, 2019, 82(2): 316-324. DOI:10.4315/0362-028X.JFP-18-352 [13] Guarino A, Guandalini S, Lo Vecchio A. Probiotics for prevention and treatment of diarrhea. Journal of Clinical Gastroenterology, 2015, 49 Suppl: S37-S45. [14] Acke E, McGill K, Golden O, Jones BR, Fanning S, Whyte P. Prevalence of thermophilic Campylobacter species in household cats and dogs in Ireland. Veterinary Record, 2009, 164(2): 44-47. [15] Rossi M, Hä nninen ML, Revez J, Hannula M, Zanoni RG. Occurrence and species level diagnostics of Campylobacter spp. in healthy and diarrheic dogs and cats. Veterinary Microbiology, 2008, 129(3/4): 304-314. [16] Chaban B, Ngeleka M, Hill JE. Detection and quantification of 14Campylobacter species in pet dogs reveals an increase in species richness in feces of diarrheic animals. BMC Microbiology, 2010, 10: 73. DOI:10.1186/1471-2180-10-73 [17] Sandberg M, Bergsjø B, Hofshagen M, Skjerve E, Kruse H. Risk factors for Campylobacter infection in Norwegian cats and dogs. Preventive Veterinary Medicine, 2002, 55(4): 241-253. DOI:10.1016/S0167-5877(02)00095-8 [18] Sancak AA, Rutgers HC, Hart CA, Batt RM. Prevalence of enteropathic Escherichia coli in dogs with acute and chronic diarrhoea. Veterinary Record, 2004, 154(4): 101-106. DOI:10.1136/vr.154.4.101 [19] Watson VE, Jacob ME, Flowers JR, Strong SJ, DebRoy C, Gookin JL. Association of atypical enteropathogenic Escherichia coli with diarrhea and related mortality in kittens. Journal of Clinical Microbiology, 2017, 55(9): 2719-2735. DOI:10.1128/JCM.00403-17 [20] Arsevska E, Singleton D, Sánchez-Vizcaíno F, Williams N, Jones PH, Smyth S, Heayns B, Wardeh M, Radford AD, Dawson S, Noble PJM, Davies RH. Small animal disease surveillance:GI disease and salmonellosis. Veterinary Record, 2017, 181(9): 228-232. DOI:10.1136/vr.j3642 [21] Cave NJ, Marks SL, Kass PH, Melli AC, Brophy MA. Evaluation of a routine diagnostic fecal panel for dogs with diarrhea. Journal of the American Veterinary Medical Association, 2002, 221(1): 52-59. DOI:10.2460/javma.2002.221.52 [22] Sabshin SJ, Levy JK, Tupler T, Tucker SJ, Greiner EC, Leutenegger CM. Enteropathogens identified in cats entering a Florida animal shelter with normal feces or diarrhea. Journal of the American Veterinary Medical Association, 2012, 241(3): 331-337. DOI:10.2460/javma.241.3.331 [23] Schneeberg A, Rupnik M, Neubauer H, Seyboldt C. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe, 2012, 18(5): 484-488. DOI:10.1016/j.anaerobe.2012.08.002 [24] Pugh CA, Bronsvoort BMDC, Handel IG, Querry D, Rose E, Summers KM, Clements DN. Incidence rates and risk factor analyses for owner reported vomiting and diarrhoea in Labrador Retrievers-findings from the Dogslife Cohort. Preventive Veterinary Medicine, 2017, 140: 19-29. DOI:10.1016/j.prevetmed.2017.02.014 [25] Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, Kachroo P, Ivanov I, Minamoto Y, Dillman EM, Steiner JM, Cook AK, Toresson L. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS One, 2012, 7(12): e51907. DOI:10.1371/journal.pone.0051907 [26] Guard BC, Barr JW, Reddivari L, Klemashevich C, Jayaraman A, Steiner JM, Vanamala J, Suchodolski JS. Characterization of microbial dysbiosis and metabolomic changes in dogs with acute diarrhea. PLoS One, 2015, 10(5): e0127259. DOI:10.1371/journal.pone.0127259 [27] Suchodolski JS, Foster ML, Sohail MU, Leutenegger C, Queen EV, Steiner JM, Marks SL. The fecal microbiome in cats with diarrhea. PLoS One, 2015, 10(5): e0127378. DOI:10.1371/journal.pone.0127378 [28] 应世吉. 犬呕吐腹泻综合征的原因分析与合理用药. 动物医学进展, 2003, 24(3): 121-122. [29] Guardabassi L, Schwarz S, Lloyd DH. Pet animals as reservoirs of antimicrobial-resistant bacteria:review. Journal of Antimicrobial Chemotherapy, 2004, 54(2): 321-332. DOI:10.1093/jac/dkh332 [30] German AJ, Halladay LJ, Noble PJ. First-choice therapy for dogs presenting with diarrhoea in clinical practice. Veterinary Record, 2010, 167(21): 810-814. DOI:10.1136/vr.c4090 [31] Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children:a meta-analysis. Digestive Diseases and Sciences, 2002, 47(11): 2625-2634. DOI:10.1023/A:1020501202369 [32] Gómez-Gallego C, Junnila J, Männikkö S, Hämeenoja P, Valtonen E, Salminen S, Beasley S. A canine-specific probiotic product in treating acute or intermittent diarrhea in dogs:a double-blind placebo-controlled efficacy study. Veterinary Microbiology, 2016, 197: 122-128. DOI:10.1016/j.vetmic.2016.11.015 [33] Torres-Henderson C, Summers S, Suchodolski J, Lappin MR. Effect of Enterococcus faecium strain SF68 on gastrointestinal signs and fecal microbiome in cats administered amoxicillin-clavulanate. Topics in Companion Animal Medicine, 2017, 32(3): 104-108. DOI:10.1053/j.tcam.2017.11.002 [34] Swanson KS, Grieshop CM, Flickinger EA, Bauer LL, Chow J, Wolf BW, Garleb KA, Fahey GC Jr. Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. The Journal of Nutrition, 2002, 132(12): 3721-3731. DOI:10.1093/jn/132.12.3721 [35] Rinkinen M, Westermarck E, Salminen S, Ouwehand AC. Absence of host specificity for in vitro adhesion of probiotic lactic acid bacteria to intestinal mucus. Veterinary Microbiology, 2003, 97(1/2): 55-61. [36] Lahrssen M, Zentek J. Efficacy of probiotic feed additives:guidelines for the evaluation of the efficiency of microorganisms in dogs, cats, and horses. Deutsche tierarztliche Wochenschrift, 2002, 109(1): 22-25. [37] Schmitz S, Suchodolski J. Understanding the canine intestinal microbiota and its modification by pro-, pre-and synbiotics-what is the evidence?. Veterinary Medicine and Science, 2016, 2(2): 71-94. DOI:10.1002/vms3.17 [38] EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Rychen G, Aquilina G, Azimonti G, Bampidis V, de Lourdes Bastos M, Bories G, Chesson A, Cocconcelli P S, Flachowsky G, Gropp J, Kolar B, Kouba M, López-Alonso M, Puente SL, Mantovani A, Mayo B, Ramos F, Villa RE, Wallace RJ, Wester P, Brozzi R, Saarela M. Safety and efficacy of Lactobacillus acidophilus D2/CSL (Lactobacillus acidophilus CECT 4529) as a feed additive for cats and dogs. EFSA Journal, 2018, 16(5): e05278. [39] European commission. Commission Implementing Regulation (EU) 2017/2312 of 13 December 2017 concerning the authorisation of a new use of the preparation of Bacillus subtilis C-3102(DSM 15544) as a feed additive for sows, suckling piglets and dogs (holder of the authorisation Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office).. Official Journal of the European Union, 2017, L331/41. [40] Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, Vélez E, Perdigón G. Beneficial effects of probiotic consumption on the immune system. Annals of Nutrition and Metabolism, 2019, 74(2): 115-124. DOI:10.1159/000496426 [41] Ogunremi OR, Sanni AI, Agrawal R. Probiotic potentials of yeasts isolated from some cereal-based Nigerian traditional fermented food products. Journal of Applied Microbiology, 2015, 119(3): 797-808. DOI:10.1111/jam.12875 [42] Sanz Y. Ecological and functional implications of the acid-adaptation ability of Bifidobacterium:a way of selecting improved probiotic strains. International Dairy Journal, 2007, 17(11): 1284-1289. DOI:10.1016/j.idairyj.2007.01.016 [43] Martins FS, Miranda IC, Rosa CA, Nicoli JR, Neves MJ. Effect of the trehalose levels on the screening of yeast as probiotic by in vivo and in vitro assays. Brazilian Journal of Microbiology, 2008, 39(1): 50-55. DOI:10.1590/S1517-83822008000100012 [44] Galdeano CM, Perdigón G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. Journal of Applied Microbiology, 2004, 97(4): 673-681. DOI:10.1111/j.1365-2672.2004.02353.x [45] Boonaert CJP, Rouxhet PG. Surface of lactic acid bacteria:relationships between chemical composition and physicochemical properties. Applied and Environmental Microbiology, 2000, 66(6): 2548-2554. DOI:10.1128/AEM.66.6.2548-2554.2000 [46] Duary RK, Rajput YS, Batish VK, Grover S. Assessing the adhesion of putative indigenous probiotic lactobacilli to human colonic epithelial cells. The Indian Journal of Medical Research, 2011, 134(5): 664-671. DOI:10.4103/0971-5916.90992 [47] Tuo YF, Yu HL, Ai LZ, Wu ZJ, Guo BH, Chen W. Aggregation and adhesion properties of 22Lactobacillus strains. Journal of Dairy Science, 2013, 96(7): 4252-4257. DOI:10.3168/jds.2013-6547 [48] Chelliah R, Ramakrishnan SR, Prabhu PR, Antony U. Evaluation of antimicrobial activity and probiotic properties of wild-strain Pichia kudriavzevii isolated from frozen idli batter. Yeast, 2016, 33(8): 385-401. DOI:10.1002/yea.3181 [49] Del Re B, Sgorbati B, Miglioli M, Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Letters in Applied Microbiology, 2000, 31(6): 438-442. DOI:10.1046/j.1365-2672.2000.00845.x [50] Divya JB, Varsha KK, Nampoothiri KM. Newly isolated lactic acid bacteria with probiotic features for potential application in food industry. Applied Biochemistry and Biotechnology, 2012, 167(5): 1314-1324. DOI:10.1007/s12010-012-9561-7 [51] Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hö rmannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, Phothirath P, Solano-Aguilar G, Vaughan E. Safety assessment of probiotics for human use. Gut Microbes, 2010, 1(3): 164-185. DOI:10.4161/gmic.1.3.12127 [52] De Melo Pereira GV, De Oliveira Coelho B, Magalhã es Júnior AI, Thomaz-Soccol V, Soccol CR. How to select a probiotic? A review and update of methods and criteria. Biotechnology Advances, 2018, 36(8): 2060-2076. DOI:10.1016/j.biotechadv.2018.09.003 [53] Liu Y, Ding SY, Dietrich R, Mä rtlbauer E, Zhu K. A Biosurfactant-inspired heptapeptide with improved specificity to kill MRSA. Angewandte Chemie International Edition, 2017, 56(6): 1486-1490. DOI:10.1002/anie.201609277 [54] Liu Y, Ding SY, Shen JZ, Zhu K. Nonribosomal antibacterial peptides that target multidrug-resistant bacteria. Natural Product Reports, 2019, 36(4): 573-592. DOI:10.1039/C8NP00031J [55] Cotter PD, Hill C, Ross RP. Bacteriocins:developing innate immunity for food. Nature Reviews Microbiology, 2005, 3(10): 777-788. DOI:10.1038/nrmicro1273 [56] Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CGM. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(18): 7617-7621. DOI:10.1073/pnas.0700440104 [57] Piewngam P, Zheng Y, Nguyen TH, Dickey SW, Joo HS, Villaruz AE, Glose KA, Fisher EL, Hunt RL, Li B, Chiou J, Pharkjaksu S, Khongthong S, Cheung GYC, Kiratisin P, Otto M. Pathogen elimination by probiotic Bacillus via signalling interference. Nature, 2018, 562(7728): 532-537. DOI:10.1038/s41586-018-0616-y [58] Medellin-Peñ a MJ, Wang HF, Johnson R, Anand S, Griffiths MW. Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Applied and Environmental Microbiology, 2007, 73(13): 4259-4267. DOI:10.1128/AEM.00159-07 [59] Li JR, Wang WL, Xu SX, Magarvey NA, McCormick JK. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(8): 3360-3365. DOI:10.1073/pnas.1017431108 [60] Wells JM, Rossi O, Meijerink M, Van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(S1): 4607-4614. [61] Yanagihara S, Kanaya T, Fukuda S, Nakato G, Hanazato M, Wu XR, Yamamoto N, Ohno H. Uromodulin-SlpA binding dictates Lactobacillus acidophilus uptake by intestinal epithelial M cells. International Immunology, 2017, 29(8): 357-363. DOI:10.1093/intimm/dxx043 [62] Campeotto F, Suau A, Kapel N, Magne F, Viallon V, Ferraris L, Waligora-Dupriet AJ, Soulaines P, Leroux B, Kalach N, Dupont C, Butel MJ. A fermented formula in pre-term infants:clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. British Journal of Nutrition, 2011, 105(12): 1843-1851. DOI:10.1017/S0007114510005702 [63] Matsuguchi T, Takagi A, Matsuzaki T, Nagaoka M, Ishikawa K, Yokokura T, Yoshikai Y. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clinical and Diagnostic Laboratory Immunology, 2003, 10(2): 259-266. DOI:10.1128/CDLI.10.2.259-266.2003 [64] Kim Y, Kim SH, Whang KY, Kim YJ, Oh S. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. Journal of Microbiology and Biotechnology, 2008, 18(7): 1278-1285. [65] Medina M, Izquierdo E, Ennahar S, Sanz Y. Differential immunomodulatory properties of Bifidobacterium logum strains:relevance to probiotic selection and clinical applications. Clinical & Experimental Immunology, 2007, 150(3): 531-538. [66] Fukushima Y, Kawata Y, Hara H, Terada A, Mitsuoka T. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. International Journal of Food Microbiology, 1998, 42(1/2): 39-44. [67] Schiffrin EJ, Blum S. Interactions between the microbiota and the intestinal mucosa. European Journal of Clinical Nutrition, 2002, 56(3): S60-S64. [68] Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunology & Medical Microbiology, 2002, 32(2): 105-110. [69] Neeser JR, Granato D, Rouvet M, Servin A, Teneberg S, Karlsson KA. Lactobacillus johnsonii La1 shares carbohydrate-binding specificities with several enteropathogenic bacteria. Glycobiology, 2000, 10(11): 1193-1199. DOI:10.1093/glycob/10.11.1193 [70] Fujiwara S, Hashiba H, Hirota T, Forstner JF. Inhibition of the binding of enterotoxigenic Escherichia coli Pb176 to human intestinal epithelial cell line HCT-8 by an extracellular protein fraction containing BIF of Bifidobacterium longum SBT2928:suggestive evidence of blocking of the binding receptor gangliotetraosylceramide on the cell surface. International Journal of Food Microbiology, 2001, 67(1/2): 97-106. [71] Valeriano VD, Bagon BB, Balolong MP, Kang DK. Carbohydrate-binding specificities of potential probiotic Lactobacillus strains in porcine jejunal (IPEC-J2) cells and porcine mucin. Journal of Microbiology, 2006, 54(7): 510-519. [72] Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature, 2011, 469(7331): 543-547. DOI:10.1038/nature09646 [73] Ma Y, Wang DC, Li Q, Fang SP. The study on the application of probiotics in pet food. Journal of Xihua University (Natural Science), 2011, 30(1): 103-106. (in Chinese)
马嫄, 王德纯, 李庆, 方升平. 益生菌在宠物食品中的应用研究. 西华大学学报(自然科学版), 2011, 30(1): 103-106. [74] Suchodolski JS. Companion animals symposium:microbes and gastrointestinal health of dogs and cats. Journal of Animal Science, 2011, 89(5): 1520-1530. DOI:10.2527/jas.2010-3377 [75] Boirivant M, Strober W. The mechanism of action of probiotics. Current Opinion in Gastroenterology, 2007, 23(6): 679-692. DOI:10.1097/MOG.0b013e3282f0cffc [76] de Moreno de LeBlanc A, Dogi CA, Galdeano CM, Carmuega E, Weill R, Perdigón G. Effect of the administration of a fermented milk containing Lactobacillus casei DN-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunology, 2008, 9: 27. DOI:10.1186/1471-2172-9-27 [77] Eun CS, Kim YS, Han DS, Choi JH, Lee AR, Park YK. Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. APMIS, 2011, 119(1): 49-56. DOI:10.1111/j.1600-0463.2010.02691.x [78] Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. The Canadian Veterinary Journal, 2011, 52(1): 43-46. [79] Weese JS, Arroyo L. Bacteriological evaluation of dog and cat diets that claim to contain probiotics. The Canadian Veterinary Journal, 2003, 44(3): 212-216. [80] Cui YF, Liu Y, Liu XY, Xia X, Ding SY, Zhu K. Evaluation of the toxicity and toxicokinetics of cereulide from an emetic Bacillus cereus strain of milk origin. Toxins, 2016, 8(6): 156. DOI:10.3390/toxins8060156 [81] Cui YF, Liu XY, Dietrich R, Märtlbauer E, Cao J, Ding SY, Zhu K. Characterization of Bacillus cereus isolates from local dairy farms in China. FEMS Microbiology Letters, 2016, 363(12): fnw096. DOI:10.1093/femsle/fnw096 [82] Zhu K, Hölzel CS, Cui YF, Mayer R, Wang Y, Dietrich R, Didier A, Bassitta R, Märtlbauer E, Ding SY. Probiotic Bacillus cereus strains, a potential risk for public health in China. Frontiers in Microbiology, 2016, 7: 718. [83] Cui YF, Wang SL, Ding SY, Shen JZ, Zhu K. Toxins and mobile antimicrobial resistance genes in Bacillus probiotics constitute a potential risk for One Health. Journal of Hazardous Materials, 2020, 382: 121266. DOI:10.1016/j.jhazmat.2019.121266 [84] Liu XY, Ding SY, Shi PJ, Dietrich R, Märtlbauer E, Zhu K. Non-hemolytic enterotoxin of Bacillus cereus induces apoptosis in Vero cells. Cellular Microbiology, 2017, 19(4): e12684. DOI:10.1111/cmi.12684 [85] Cui YF, Märtlbauer E, Dietrich R, Luo HL, Ding SY, Zhu K. Multifaceted toxin profile, an approach toward a better understanding of probiotic Bacillus cereus. Critical Reviews in Toxicology, 2019, 49(4): 342-356. DOI:10.1080/10408444.2019.1609410 [86] Fu SZ, Yang Q, He FL, Lan RT, Hao JW, Ni P, Liu Y, Li RJ. National safety survey of animal-use commercial probiotics and their spillover effects from farm to humans:an emerging threat to public health. Clinical Infectious Diseases, 2019. DOI:10.1093/cid/ciz642